FBR signs deal to build world’s first 3D printed brick homes


Published 06-SEP-2016 16:11 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Fastbrick Robotics Limited (ASX:FBR) has signed a framework agreement with Perth based builder Archistruct Builders & Designers to construct the world’s first 3D printed brick homes.

The agreement between the two parties is non-binding and non-exclusive in nature, meaning FBR can seek commercial opportunities with other builders.

A total of eleven 3D printed brick homes will be built using FBR’s Hadrian X commercial prototype technology.

The homes will be built within the confines of a standard building environment with each home to have a minimum floor plan of 180m2 and consist of at least three bedrooms and two bathrooms.

Construction of the homes will commence following the completion of the Hadrian X prototype.

The Hadrian X will supersede the award winning Hadrian 105 that printed the world’s first multi-room structure.

The Hadrian X is able to able to lay 1000 bricks per hour compared to the human average of 300-500 per day.

The framework agreement gives Archistruct Builders & Designs the first construction rights beyond the initial 10 homes, with the 11th home to be charged at standard commercial rates.

The supply of the land and all the building services will be covered by Archistruct Builders & Designs.

In future, Archistruct will sub-contract FBR to build the brickwork from slab to cap using the Hadrian X as part of the residential building process.

A formal agreement between the two parties detailing the terms of the partnership will soon be finalised.

Should the 11 homes be built as planned, FBR could further make a name for itself in the construction industry on top of the copious amounts of press coverage it has received around the world recently for its potentially industry changing technology including this article in June: ASX Robot Tech Set to Build Houses 10 x Faster than Normal by the Next Tech Stock.

Interestingly since June FBR’s share price has risen over 180% and now sits at 7.6 cents.

However, trading trends to date for FBR are not an indication of future share price performance and these should not form the basis of an investment decision.

Whilst the company is still early stage and the technology largely still unproven in a commercial environment, the ability to transform the housing industry is a real opportunity that today’s agreement validates.

FBR’s aim is to have the Hadrian X build homes faster, with more accuracy and safer than the current manual labour methods.

With a labour shortage in the bricklaying industry, FBR may have the solution the construction industry has long been waiting for.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free